-
Electronic (PDF)
-
Site License
-
Enterprisewide
Acute Lymphocytic Leukemia (ALL) Clinical Trials Review Q4, 2010
GlobalData, October 2010, Pages: 65
Acute Lymphocytic Leukemia (ALL) Clinical Trials Review Q4, 2010
Summary
Our clinical trial report, “Acute Lymphocytic Leukemia (ALL) Global Clinical Trials Review, Q4, 2010"” provides data on the Acute Lymphocytic Leukemia (ALL) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Acute Lymphocytic Leukemia (ALL). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Acute Lymphocytic Leukemia (ALL).
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Acute Lymphocytic Leukemia (ALL)
2.2 Report Guidance
3 Clinical Trials by Region
3.1 Clinical Trials by Country
3.1.1 Top Countries Contributing to Clinical Trials in Asia-Pacific
3.1.2 Top Five Countries Contributing to Clinical Trials in Europe
3.1.3 Top Countries Contributing to Clinical Trials in North America
3.1.4 Top Five Countries Contributing to Clinical Trials in Central and South America
3.1 Clinical Trials by BRIC Nations
4 Clinical Trials by Phase
4.1 In Progress Trials by Phase
5 Clincial Trials by Trial Status
5.1 Unaccomplished Trials of Acute Lymphocytic Leukemia (ALL)
6 Subjects Recruited Over a period
7 Prominent Sponsors
7.1 Top 10 Companies Participating in Acute Lymphocytic Leukemia (ALL) Clinical Trials
8 Prominent Drug Comparision
9 Clinical Trial Profiles
9.1 Clinical Trial Overview of Top 20 Companies
9.1.1 St. Jude Children’s Research Hospital, Inc.
9.1.2 Bristol-Myers Squibb Company
9.1.3 Merck & Co., Inc.
9.1.4 Sanofi-Aventis
9.1.5 Genzyme Corporation
9.1.6 Novartis AG
9.1.7 Micromet, Inc.
9.1.8 Onconova Therapeutics, Inc
9.1.9 AstraZeneca PLC
9.1.10 Callisto Pharmaceuticals, Inc.
9.1.11 Hana Biosciences, Inc.
9.1.12 Abbott Laboratories
9.1.13 Astex Therapeutics Limited
9.1.14 BioCryst Pharmaceuticals, Inc.
9.1.15 Boehringer Ingelheim GmbH
9.1.16 Cephalon, Inc.
9.1.17 CytRx Corporation
9.1.18 Deciphera Pharmaceuticals, LLC
9.1.19 Eli Lilly and Company
9.1.20 Erimos Pharmaceuticals, LLC
9.2 Clinical Trial Overview by Top 20 Universities / Institutes / Hospitals
9.2.1 National Cancer Institute
9.2.2 The University of Texas M. D. Anderson Cancer Center
9.2.3 Dana-Farber Cancer Institute
9.2.4 Fred Hutchinson Cancer Research Center-Technology Transfer
9.2.5 Memorial Sloan Kettering Cancer Center
9.2.6 Johann Wolfgang Goethe University Hospitals
9.2.7 Masonic Cancer Center
9.2.8 National Heart, Lung, and Blood Institute
9.2.9 Emory University
9.2.10 Sidney Kimmel Comprehensive Cancer Center
9.2.11 Therapeutic Advances in Childhood Leukemia Consortium
9.2.12 University of California, San Francisco
9.2.13 University of Pennsylvania
9.2.14 Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
9.2.15 Beckman Research Institute
9.2.16 Children's Hospital Center for Cancer and Blood Disorders
9.2.17 Duke University
9.2.18 Indiana University School of Medicine
9.2.19 Massachusetts General Hospital
9.2.20 Roswell Park Cancer Institute
10 Appendix
10.1 Abbreviations
10.2 Definitions
10.3 Secondary Research
10.4 About Us
10.5 Contact Us
10.6 Disclaimer
10.7 Source
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
